These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33514352)

  • 1. Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy.
    Chen K; Sun J; Zhao H; Jiang R; Zheng J; Li Z; Peng J; Shen H; Zhang K; Zhao J; Zhu S; Wang Y; Yang F; Wang J
    Mol Cancer; 2021 Jan; 20(1):23. PubMed ID: 33514352
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.
    Pulverer W; Kruusmaa K; Schönthaler S; Huber J; Bitenc M; Bachleitner-Hofmann T; Bhangu JS; Oehler R; Egger G; Weinhäusel A
    Curr Issues Mol Biol; 2021 Oct; 43(3):1419-1435. PubMed ID: 34698107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Nucleic Acid in Tumor: Bioinformatics Approaches.
    Angeli D
    Methods Mol Biol; 2021; 2292():95-104. PubMed ID: 33651354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
    Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
    Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.
    Keup C; Suryaprakash V; Hauch S; Storbeck M; Hahn P; Sprenger-Haussels M; Kolberg HC; Tewes M; Hoffmann O; Kimmig R; Kasimir-Bauer S
    Genome Med; 2021 May; 13(1):85. PubMed ID: 34001236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
    Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
    Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer.
    Qvick A; Stenmark B; Carlsson J; Isaksson J; Karlsson C; Helenius G
    Mol Med; 2021 Jul; 27(1):68. PubMed ID: 34217228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.
    Dillinger T; Sheibani-Tezerji R; Pulverer W; Stelzer I; Hassler MR; Scheibelreiter J; Pérez Malla CU; Kuroll M; Domazet S; Redl E; Ely S; Brezina S; Tiefenbacher A; Rebhan K; Hübner N; Grubmüller B; Mitterhauser M; Hacker M; Weinhaeusel A; Simon J; Zeitlinger M; Gsur A; Kramer G; Shariat SF; Kenner L; Egger G
    Mol Cancer; 2022 Jan; 21(1):7. PubMed ID: 34980142
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
    Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
    Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy for the identification of intravascular large B-cell lymphoma.
    Suehara Y; Sakata-Yanagimoto M; Hattori K; Nanmoku T; Itoh T; Kaji D; Yamamoto G; Abe Y; Narita K; Takeuchi M; Matsue K; Sato T; Noguchi M; Baba N; Sakamoto T; Kusakabe M; Kurita N; Kato T; Yokoyama Y; Nishikii H; Obara N; Hasegawa Y; Chiba S
    Haematologica; 2018 Jun; 103(6):e241-e244. PubMed ID: 29472348
    [No Abstract]   [Full Text] [Related]  

  • 14. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
    Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
    Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
    Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
    Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid Biopsy and Lung Cancer.
    Pisapia P; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquid biopsy in lung cancer management.
    Satapathy S; Thirunavukkarasu B; Jain D
    Indian J Pathol Microbiol; 2024 Jul; 67(3):492-501. PubMed ID: 39011609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
    Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
    Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.
    Casagrande GMS; Silva MO; Reis RM; Leal LF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
    Liu AP; Northcott PA; Robinson GW; Gajjar A
    Lab Invest; 2022 Feb; 102(2):134-142. PubMed ID: 34934181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.